FDA recommends we conduct a randomized, double-blinded, placebo-controlled Phase II for Intravenous (IV) and Inhaled Ampion to allow consideration of...
CAMBRIDGE, Mass., March 03, 2021 (World NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical corporation centered on...
SECAUCUS, N.J., March 02, 2021 (Globe NEWSWIRE) -- The Children’s Put, Inc. (Nasdaq: PLCE) now introduced that, in conjunction with...
MINNEAPOLIS, March 2, 2021 /PRNewswire/ --Q4 2020 Highlights Comparable sales grew 20.5 percent, reflecting comparable traffic growth of 6.5 percent...
TipRanksBillionaire Steven Cohen Picks Up These 3 “Strong Buy” StocksLast 7 days, the NASDAQ slipped beneath 13,200, earning the net...
EXTON, Pa.--(Company WIRE)--Feb 26, 2021--Bentley Methods, Incorporated (Nasdaq: BSY), the infrastructure engineering application firm, now announced that its Board of...
Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced financial results for the period ended December 31, 2020."We are encouraged...
- UPLIFT, a single-arm registration strategy evaluating upifitamab rilsodotin (UpRi) in platinum-resistant ovarian cancer, on track to begin in Q1...
VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing...
Company demonstrates resilience despite COVID-19 challenges: Financial situation secure and development programs progressingConference call begins today at 4:30 p.m. (ET)BASKING...
2021 Vaccine Manufacturing: Raises lower end of global manufacturing plan for 2021 from 600 million doses to 700 million doses;...
2020 Net Revenues of $83.1 Million Increased 19% over 2019Fourth Quarter Net Revenues of $24.7 Million or $80 Per BottleNew...
SAN FRANCISCO, Feb. 25, 2021 /PRNewswire/ -- Marin Software Incorporated (NASDAQ: MRIN), a leading provider of digital marketing software for...
- Outlined strategy to build integrated cell therapy company and the Company’s “2-2-5-2” five-year core value drivers -- Reported compelling...
GUADALAJARA, Mexico, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the...
Two Phase 3 trials, EMERGENT-2 and EMERGENT-4, initiated evaluating KarXT for the treatment of psychosis in adults with schizophreniaResults from...
Achieved 2020 financial guidance2021 guidance reflects increased investments in wholly owned pipeline to drive future revenue growthWebcast today, February 24,...
TipRanks3 Stocks Goldman Sachs Suggests Are All set to Rip GreaterIs the bull market place about to choose a lengthy...
